NasdaqCM - Nasdaq Real Time Price USD

HeartBeam, Inc. (BEAT)

Compare

2.1400

0.0000

(0.00%)

At close: January 21 at 4:00:01 PM EST

2.1400

0.00

(0.00%)

After hours: January 21 at 4:39:12 PM EST

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

SANTA CLARA, Calif., December 23, 2024--HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

Business Wire 29 days ago

BEAT
0.00%
BEATW
HeartBeam’s arrhythmia assessment system gains FDA 510(k) clearance

Distinguished by its credit card size and cable-free design, the device is claimed to be the first of its kind to be cleared by the US regulator.

Medical Device Network last month

BEATW
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

SANTA CLARA, Calif., December 16, 2024--HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

Business Wire last month

BEAT
0.00%
BEATW
HeartBeam And 2 Other US Penny Stocks With Promising Potential

As the U.S. stock market reaches record highs, driven by strong tech earnings and anticipation of Federal Reserve insights, investors are exploring diverse opportunities across various sectors. Penny stocks, though often associated with speculative trading, remain a compelling area for those seeking potential value in smaller or newer companies. By focusing on penny stocks with robust financials and growth potential, investors can uncover promising opportunities that might otherwise go...

Simply Wall St. last month

CHR

GSMGW

JVA
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

SANTA CLARA, Calif., November 19, 2024--HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

Business Wire 2 months ago

BEAT
0.00%
BEATW
HeartBeam Inc (BEAT) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ...

Despite a net loss and cash constraints, HeartBeam Inc (BEAT) remains optimistic about FDA clearance and its groundbreaking ECG technology.

GuruFocus.com 2 months ago

BEATW
HeartBeam Reports Third Quarter 2024 Results

SANTA CLARA, Calif., November 07, 2024--HeartBeam Reports Third Quarter 2024 Results

Business Wire 2 months ago

BEAT
0.00%
BEATW
Spotlight On US Penny Stocks In October 2024

As the U.S. stock market experiences a downturn, particularly impacting major tech companies, investors are reassessing their strategies amid fluctuating earnings reports and economic indicators. In this climate of uncertainty, penny stocks—though often overlooked—continue to present intriguing opportunities for growth, especially when they boast solid financial health. These smaller or newer companies can offer unique value and growth prospects that larger firms might miss, making them an...

Simply Wall St. 2 months ago

NEOV

NEOVW

RSKD
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif., October 31, 2024--HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

Business Wire 2 months ago

BEAT
0.00%
BEATW
HeartBeam, Inc. (BEAT): A Bull Case Theory

We came across a bullish thesis on HeartBeam, Inc. (BEAT) on Triple S Special Situations Investing’s Substack by TripleS Special Situations. In this article, we will summarize the bulls’ thesis on BEAT. HeartBeam, Inc.’s share was trading at $2.30 as of Oct 24th. HeartBeam, Inc. (NASDAQ:BEAT) is on the brink of potentially transforming cardiac care with its […]

Insider Monkey 2 months ago

BEATW
HeartBeam Named "Rising Star" at the 6th Annual Digital Health Hub Foundation Awards

SANTA CLARA, Calif., October 24, 2024--HeartBeam Named "Rising Star" at the 6th Annual Digital Health Hub Foundation Awards

Business Wire 2 months ago

BEAT
0.00%
BEATW
HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

SANTA CLARA, Calif., October 17, 2024--HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

Business Wire 3 months ago

BEAT
0.00%
BEATW
HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

SANTA CLARA, Calif., September 24, 2024--HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

Business Wire 3 months ago

BEAT
0.00%
BEATW
Is HeartBeam (NASDAQ:BEAT) In A Good Position To Invest In Growth?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Simply Wall St. 4 months ago

BEAT
0.00%
BEATW
HeartBeam Names Timothy Cruickshank as Chief Financial Officer

SANTA CLARA, Calif., September 10, 2024--HeartBeam Names Timothy Cruickshank as Chief Financial Officer

Business Wire 4 months ago

BEAT
0.00%
BEATW
HeartBeam Reports Second Quarter 2024 Results

SANTA CLARA, Calif., August 14, 2024--HeartBeam Reports Second Quarter 2024 Results

Business Wire 5 months ago

BEAT
0.00%
BEATW
HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif., August 01, 2024--HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

Business Wire 5 months ago

BEAT
0.00%
BEATW
HeartBeam Added to Russell Microcap® Index

SANTA CLARA, Calif., July 01, 2024--HeartBeam Added to Russell Microcap® Index

Business Wire 6 months ago

BEAT
0.00%
BEATW
Anumana sees results from pulmonary hypertension detecting algorithm trial

The multi-site trial examined 39,823 potential patients for signs of pulmonary hypertension finding the device was able to identify the condition in most patients.

Medical Device Network 6 months ago

BEATW
Caristo touts study showing accuracy of its CaRi-Heart technology

The ORFAN study analysed results from 40,000 patients undergoing cardiac computed tomography angiography in the UK.

Medical Device Network 7 months ago

GLDAF

BEATW

Performance Overview

Return	BEAT	S&P 500
YTD	-0.93%	+2.41%
1-Year	+28.92%	+24.99%
3-Year	-25.17%	+34.95%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

HeartBeam, Inc. (BEAT)

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam’s arrhythmia assessment system gains FDA 510(k) clearance

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

HeartBeam And 2 Other US Penny Stocks With Promising Potential

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

HeartBeam Inc (BEAT) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ...

HeartBeam Reports Third Quarter 2024 Results

Spotlight On US Penny Stocks In October 2024

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

HeartBeam, Inc. (BEAT): A Bull Case Theory

HeartBeam Named "Rising Star" at the 6th Annual Digital Health Hub Foundation Awards

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

Is HeartBeam (NASDAQ:BEAT) In A Good Position To Invest In Growth?

HeartBeam Names Timothy Cruickshank as Chief Financial Officer

HeartBeam Reports Second Quarter 2024 Results

HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

HeartBeam Added to Russell Microcap® Index

Anumana sees results from pulmonary hypertension detecting algorithm trial

Caristo touts study showing accuracy of its CaRi-Heart technology

Performance Overview